Synvista Therapeutics, Inc.
SYNI
$0.00
$0.000.00%
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.96M | 10.10M | 12.53M | 15.65M | 17.30M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 438.90K | 515.50K | 710.00K | 234.30K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 350.50K |
| Total Current Assets | 8.40M | 10.61M | 13.24M | 15.88M | 17.65M |
|
|
|||||
| Total Current Assets | 8.40M | 10.61M | 13.24M | 15.88M | 17.65M |
| Net Property, Plant & Equipment | 25.10K | 18.80K | 18.30K | 17.10K | 16.50K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 325.50K | 352.90K | 380.30K | 407.60K | 835.00K |
| Total Assets | 8.75M | 10.99M | 13.64M | 16.71M | 18.50M |
|
|
|||||
| Total Accounts Payable | 761.10K | 626.20K | 582.70K | 1.50M | 566.10K |
| Total Accrued Expenses | 1.03M | 717.80K | 561.60K | 458.70K | 827.80K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 2.38M | 1.88M | 1.38M | 875.00K | 375.00K |
| Total Other Current Liabilities | 2.38M | 1.88M | 1.38M | 875.00K | 375.00K |
| Total Current Liabilities | 4.17M | 3.22M | 2.52M | 2.84M | 1.77M |
|
|
|||||
| Total Current Liabilities | 4.17M | 3.22M | 2.52M | 2.84M | 1.77M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.17M | 3.22M | 2.52M | 2.84M | 1.77M |
|
|
|||||
| Common Stock & APIC | 282.58M | 280.69M | 278.79M | 276.86M | 274.93M |
| Retained Earnings | -278.10M | -273.03M | -267.77M | -263.09M | -258.30M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 4.48M | 7.67M | 11.02M | 13.77M | 16.63M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K |
|
|
|||||
| Total Common Equity | 4.48M | 7.67M | 11.02M | 13.77M | 16.63M |
| Total Preferred Equity | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.58M | 7.77M | 11.12M | 13.87M | 16.73M |
|
|
|||||
